非动脉瘤性蛛网膜下腔出血的临床病程与结局:一项单中心回顾性研究
该单中心回顾性研究纳入2005至2020年Tampere大学医院的216例非动脉瘤性蛛网膜下腔出血(214例患者),评估2个月GOS结局。典型中脑周围出血模式(PSAH)患者97%(75/77)结局良好,非中脑周围SAH(NPSAH)患者86%(84/98)结局良好。多变量分析显示意识丧失(aOR 214.67,95%CI 17.62-2615.89)和Fisher 4级出血模式(aOR 23.32,95%CI 1.40-387.98)与不良结局风险增加相关。
要点
- 非动脉瘤性SAH总体预后良好,尤其PSAH患者97%(75/77)结局良好。
- 意识丧失(aOR 214.67)和Fisher 4级出血(aOR 23.32)与不良结局风险增加相关。
- 20%患者出现血管痉挛,17%出现脑积水,13%需脑室造瘘。
核心结论
- 非动脉瘤性SAH对多数患者似乎预后良好,尤其是PSAH患者。
- 非动脉瘤性SAH患者仍受血管痉挛和脑积水影响,且不良结局危险因素与动脉瘤性SAH相似,提示出血严重程度而非病因与不良结局相关。
研究设计与样本
- 单中心回顾性研究,筛选2005至2020年Tampere大学医院的非动脉瘤性SAH患者,共216次出血(214例患者,2例发生>1次出血)。
- 主要关注2个月时二分法GOS评估的神经学结局,采用多变量逻辑回归分析与不良结局相关的因素。
主要发现
- PSAH患者97%(75/77)结局良好,NPSAH患者86%(84/98)结局良好。
- 多变量逻辑回归显示意识丧失(aOR 214.67,95%CI 17.62-2615.89)和Fisher 4级出血模式(aOR 23.32,95%CI 1.40-387.98)与不良结局(GOS 1-3)风险增加相关。
- 非动脉瘤性SAH患者中血管痉挛占20%,脑积水占17%,13%需脑室造瘘。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Non-aneurysmal subarachnoid hemorrhages (SAHs) are thought to have a benign clinical course compared to aneurysmal SAHs. The aim of this study is to report the clinical course and outcomes of non-aneurysmal SAHs in a large single-center study. METHODS: The patients with non-aneurysmal SAHs were screened from Tampere University Hospital from 2005 to 2020. The clinical data were collected from the patient's medical records and from the imaging studies. The primary interest was the neurological outcome assessed by dichotomized GOS at 2 months. Multivariable logistic regression was used to study the factors associated with unfavorable outcome. RESULTS: We found 216 non-aneurysmal SAHs in 214 patients (2 patients with > 1 bleed). Ninety-seven percent of patients with a typical perimesencephalic bleeding pattern SAH (PSAH) (75/77) had a favorable outcome, while 86% of patients with non-perimesencephalic SAH (NPSAH) had a favorable outcome (84/98). In a multivariable logistic regression analysis, loss of consciousness (LOC) (aOR 214.67, 95% CI 17.62-2615.89) and Fisher grade 4 bleeding pattern (aOR 23.32, 95% CI 1.40-387.98) were associated with increased risk for unfavorable outcome (GOS 1-3). Vasospasm was seen in 20% of non-aneurysmal SAH patients, hydrocephalus in 17%, and 13% needed ventriculostomy. CONCLUSIONS: Non-aneurysmal SAH seems to have a good prognosis for majority of patients, especially for patients with a PSAH. Non-aneurysmal SAH patients are however affected by vasospasm and hydrocephalus and have similar risk factors for poor outcome as patients with aneurysmal SAH. This suggests that it is the severity of the bleed rather than the etiology that associates with poor outcome.
引用
- Tarkiainen J, Hovi V, Pyysalo L, et al. The clinical course and outcomes of non-aneurysmal subarachnoid hemorrhages in a single-center retrospective study. Acta Neurochir (Wien). 2023. PMID: 37659045. doi:10.1007/s00701-023-05767-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。